Cancer
Kuda Therapeutics Success Story Highlighted by Utah Innovation Center
Kuda Therapeutics is a pre-clinical drug development company focused on novel therapies to target kidney cancer. The company’s mission is…
June 13, 2023
Utah Company Kuda Therapeutics Awarded $2 Million Grant for Cancer Research
Utah Company Kuda Therapeutics Awarded $2 Million Grant for Cancer Research Utah company, Kuda Therapeutics, received a Phase II grant…
March 9, 2023
"Media inquiries: Please contact the office's Public Information Officer, Ashley Okawa, at ashleyokawa@utah.gov or 801-518-3765."